We hypothesized that the radiomics features obtained from DWI holds great potential in improving the recurrence risk stratification of MIBC patients. Thus, we developed a radiomics nomogram and compared its performance with clinicopathological nomogram and radiomics signature in individual RFS prediction. Our results showed that the radiomics nomogram, which incorporates radiomics signatures, clinical characteristics and molecular characteristics, has greater potential to serve as a biomarker to estimate the RFS in MIBC patients. In conclusion, a radiomics nomogram may serve as a potential tool to facilitate individualized prediction of recurrence in patients with MIBC.
This abstract and the presentation materials are available to members only; a login is required.